SCHEMBL6985209

SCHEMBL6985209

CC(C)c1nc2cc(C=O)ccc2c(=O)[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
PARG Q86W56 1/20 0.42
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 1/20 0.39
TUBB4A P04350 2/20 0.37
TUBB P07437 2/20 0.37
TUBA3C P0DPH7 2/20 0.37
TUBA1B P68363 2/20 0.37
TUBA4A P68366 2/20 0.37
TUBB4B P68371 2/20 0.37
TUBB3 Q13509 2/20 0.37
TUBB2A Q13885 2/20 0.37
TUBB8 Q3ZCM7 2/20 0.37
TUBA3E Q6PEY2 2/20 0.37
TUBA1A Q71U36 2/20 0.37
TUBA1C Q9BQE3 2/20 0.37
TUBB6 Q9BUF5 2/20 0.37
TUBB2B Q9BVA1 2/20 0.37
TUBB1 Q9H4B7 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23775859 0.80 KDM4E (0.45) KDM4EPARGLMNAHSD17B10MAPT
SCHEMBL26438900 0.80 PARP1 (0.49) KDM4EPARGLMNAHSD17B10MAPT
SCHEMBL5031668 0.80 HSD17B10 (0.53) KDM4ELMNAHSD17B10KIF11TYR
SCHEMBL6983919 0.80 PARP1 (0.56) KDM4ELMNAHSD17B10MAPTIP6K1
SCHEMBL26451280 0.79 KDM4E (0.44) KDM4EPARGLMNAHSD17B10MAPT
SCHEMBL4246459 0.77 KDM4E (0.53) KDM4ELMNAHSD17B10KIF11ALDH1A1
SCHEMBL19521610 0.76 KDM4E (0.40) KDM4EPARGLMNAHSD17B10MAPT
Hydrochloric Acid SCHEMBL28023691 0.75 TUBB4A (0.53) KDM4ELMNAHSD17B10MAPTTUBB4A
SCHEMBL2614349 0.74 KDM4E (0.62) KDM4EMAPTALDH1A1RAB9A
SCHEMBL6975873 0.73 PARP1 (0.52) KDM4EPARGTUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100324029-A1 THERAPEUTIC AGENTS MERCK SHARP & DOHME CORP. 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324029-A1 THERAPEUTIC AGENTS PSEN2, PSEN1, BACE2 KDM4E 3970/4885PARG 4034/4885LMNA 1357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.